Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian HospitalNCT00256659
Hospital Outcomes: Intervention in Moderately III Patients
A study of Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 444 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 1998to Apr 1999
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
- Patients who are able to provide verbal consent for their participation will be enrolled.
Who cannot join
- Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
- Patients who refuses not to participate in the study.
- Patients who are unable to give written informed consent.
Trial locations and contacts
1 site in 1 country.
United States1 site
New York Presbyterian Hospital- Weill Medical Center
New York, New York, 10021
About this study
To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.
Read the detailed description
To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.
This is a randomized study which will compare the current Standard of Care in hospital to EARLY assessment and referrals with respect to social work services, rehabilitation, psychiatry, and nursing. In this study, the control group will receive the hospital support services provided under current system of delivery and allocation. The intervention group will not receive any new or different services not already provided to all patients at New York Presbyterian Hospital. The difference between the 2 groups will be the uniformity of screening to identify the needs of the patient in the respective area of social services, rehabilitation, psychiatric assistance, and nursing care, and the timeliness by which the referrals for support services will be placed.
Potential interventions: (In both control and experimental group)
- Social work: Discharge planning (homecare, visiting nursing services, skilled nursing facility placement).
- Rehabilitation: Physical Therapy (improve ADLs-activities of daily living).
- Psychiatry: Diagnosis and Assistance in management of Depression.
- Nursing: Prevention of in hospital falls and decubitus ulcer formation.
- Conditions
- Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
- Being tested
- Early assessment and referral to ancillary care services vs. standard care
- Keywords
- Medical inpatients, Social Work, Physical therapy, Occupational therapy, Psychiatry, Early intervention, Iatrogenic complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Early assessment and referral to ancillary care services vs. standard careBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.
Secondary outcomes (1)
To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2005 (estimated)
- Study startSep 1998
- Study completionApr 1999
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian HospitalStudies of the same condition, open and under way.
- More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 444 participants
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Investigators
- Mary E Charlson, MD, Principal investigator, Weill Medical College of Cornell UniversityJames Hollenberg, MD, Principal investigator, Weill Medical College of Cornell UniversityMark Pecker, MD, Principal investigator, Weill Medical College of Cornell UniversitySona Euster, MSW, Principal investigator, Weill Medical Center of Cornell UniversityDelia Gorga, PhD, Principal investigator, Weill Medical Center of Cornell UniversityMary Cooper, MD, Principal investigator, Weill Medical College of Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00256659
- Sponsor's protocol ID
- 9808003482
- Status last verified
- Mar 2008
- First submitted
- 17 Nov 2005
- Last updated
- 3 Apr 2008
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hospital Outcomes: Intervention in Moderately III Patients
- ClinicalTrials.gov ID
- NCT00256659
- Acronym / sponsor ID
- 9808003482
- Conditions
- Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
- Keywords
- Medical inpatients, Social Work, Physical therapy, Occupational therapy, Psychiatry, Early intervention, Iatrogenic complications
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 444 participants
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Study start
- Sep 1998
- Study completion
- Apr 1999
- First posted
- 21 Nov 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.
Detailed description
To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.
This is a randomized study which will compare the current Standard of Care in hospital to EARLY assessment and referrals with respect to social work services, rehabilitation, psychiatry, and nursing. In this study, the control group will receive the hospital support services provided under current system of delivery and allocation. The intervention group will not receive any new or different services not already provided to all patients at New York Presbyterian Hospital. The difference between the 2 groups will be the uniformity of screening to identify the needs of the patient in the respective area of social services, rehabilitation, psychiatric assistance, and nursing care, and the timeliness by which the referrals for support services will be placed.
Potential interventions: (In both control and experimental group)
- Social work: Discharge planning (homecare, visiting nursing services, skilled nursing facility placement).
- Rehabilitation: Physical Therapy (improve ADLs-activities of daily living).
- Psychiatry: Diagnosis and Assistance in management of Depression.
- Nursing: Prevention of in hospital falls and decubitus ulcer formation.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
- Patients who are able to provide verbal consent for their participation will be enrolled.
Key exclusion criteria (3 listed)
- Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
- Patients who refuses not to participate in the study.
- Patients who are unable to give written informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Early assessment and referral to ancillary care services vs. standard care | Behavioural | – |
Primary outcome
To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.
1 secondary outcome
To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2008.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mary E Charlson, MD principal investigator
Weill Medical College of Cornell University
James Hollenberg, MD principal investigator
Weill Medical College of Cornell University
Mark Pecker, MD principal investigator
Weill Medical College of Cornell University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Apr 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2008.